An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug – Paxlovid – is intended for use soon after symptoms develop in people at high risk of severe disease.
Pfizer says it stopped trials early as the initial results were so positive.
It comes the day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
Please subscribe HERE http://bit.ly/1rbfUog
#Covid #BBCNews
ROMA (ITALPRESS) – Su Mezzo (canale 49 della piattaforma satellitare gratuita di Tivusat) per tutto il mese di giugno sarà…
ANSA è la più importante agenzia d'informazione in Italia. Immagini e storie da tutto il mondo: politica, economia, cronaca, sport,…